[Form 4] Roivant Sciences Ltd. Insider Trading Activity

Rhea-AI Filing Summary

Richard Pulik, Chief Financial Officer of Roivant Sciences Ltd. (ROIV) reported the disposition of 2,341 common shares on 09/28/2025 at a price of $15.17 per share. The Form 4 states this disposition represents a net settlement of previously granted restricted stock units (RSUs) to satisfy tax withholding obligations upon vesting. After the transaction, the reporting person beneficially owns 389,508 shares. The filing was signed on behalf of Mr. Pulik by an attorney-in-fact on 09/30/2025. All information is limited to the transaction details disclosed in the Form 4.

Positive

• Transaction clearly disclosed as a net RSU settlement to satisfy tax withholding, providing transparency
• Post-transaction ownership is disclosed (389,508 shares), allowing investors to assess insider stake

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine insider tax-withholding settlement disclosed; no indication of opportunistic sale or change in control.

The Form 4 documents a small, routine disposition of 2,341 shares via net settlement of RSUs to meet tax obligations. Such transactions are common following vesting events and typically do not signal a change in insider sentiment. The filing discloses post-transaction beneficial ownership of 389,508 shares, which provides context on the insider's ongoing stake. The disclosure appears timely and properly executed by an authorized attorney-in-fact.

Securities Analyst

TL;DR: Transaction is administrative and immaterial to company valuation; no material trading signal presented.

The sale of 2,341 shares at $15.17 as a net RSU settlement represents a tax-related disposition rather than a market sell order. The magnitude of the transaction relative to the insider's remaining 389,508-share holding suggests no material shift in ownership or control. Investors should note the clear statement that this was to satisfy withholding obligations and not an outright divestiture of additional holdings.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Pulik Richard

(Last) (First) (Middle)

C/O ROIVANT SCIENCES LTD.

7TH FLOOR, 50 BROADWAY

(Street)

LONDON X0 SW1H 0DB

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Roivant Sciences Ltd. [ ROIV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

3. Date of Earliest Transaction (Month/Day/Year)
09/28/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	09/28/2025		F		2,341(1)	D	$15.17	389,508	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.

	By: /s/ Jo Chen, as Attorney-in-Fact for Richard Pulik	09/30/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Richard Pulik (ROIV) report on the Form 4 filed for 09/28/2025?

The Form 4 reports a disposition of 2,341 common shares at $15.17 per share on 09/28/2025, recorded as a net settlement of RSUs for tax withholding.

Was the 2,341-share transaction an open-market sale or a net settlement?

The filing states it was a net settlement by the issuer of RSUs previously granted to the reporting person to satisfy tax withholding obligations.

How many Roivant shares does the reporting person own after the transaction?

After the reported transaction the reporting person beneficially owns 389,508 shares.

What is the reported price per share for the transaction?

The reported price per share for the disposed shares is $15.17.

Who signed the Form 4 filing for Richard Pulik?

The Form 4 was signed by Jo Chen as Attorney-in-Fact for Richard Pulik on 09/30/2025.